2
FDI World Dental Federation asks how can industry drive innovation to improve oral health?
plus
Actualités sur Health
Zentiva to donate 100,000 packs of medicines to the Ukrainian Humanitarian Crisis
Prague (ots/PRNewswire) - Zentiva is a major developer and producer of high-quality and affordable medicines in Europe. Zentiva will donate 100,000 packs of medicines to humanitarian aid programs targeted at helping the citizens of Ukraine. The medicines will include life-saving hospital medicines, cardiovascular medicines, pain medication, and anti-infectives. The ...
plusECM Partners Inc. appoints Peter Prock as Chairman of FAMAR Group Board of Directors
Madrid (ots/PRNewswire) - FAMAR Group BoD also welcomes its new member Konstantinos Rengis ECM Partners Inc., FAMAR's major shareholder, announced today that Peter Prock is appointed as the new Chairman of the Board of Directors of FAMAR Group, a leading European contract development and manufacturing organization. "I am delighted to be joining FAMAR as Chairman at ...
plusJean-Luc Herbeaux to become Hovione CEO
Lisbon, Portugal (ots/PRNewswire) - Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione's Chief Executive Officer, effective 1st April 2022. Guy Villax, who has been Hovione's CEO for the past 25 years will now serve as a Member of the Board and shareholder. During his tenure, Hovione grew tenfold. The company currently employs 2000 ...
plusHovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Lisbon (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform. Zerion´s innovative Dispersome® technology builds on a new ...
plusTytoCare Receives CE Mark Approval for its Lung Sounds Analyzer Providing Clinicians with AI-Powered Decision Support During Remote Examinations
New York (ots/PRNewswire) - The approval will aid European healthcare providers in clinically assessing lung sound data to determine whether wheezing is detected TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, ...
plus
DTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growth
Boston, Reykjavik, Iceland and Berlin (ots/PRNewswire) - - UnitedHealth Group and Anthem veteran Pamela Stahl joins as Chief Commercial Officer (CCO) and President, North America to lead Sidekick's global commercial strategy, driving revenue growth with international pharmaceutical majors and U.S.-based payers. - Mitchell Mudra joins Sidekick from UnitedHealth Group as ...
plusNanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology
Nes Ziona, Israel and Shanghai, China (ots/PRNewswire) - Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination. In a hallmark study published recently by IMB scientists[1], subjects were ...
plusIMTIS Holdings requests Turkcell Board to Call General Assembly of Shareholders to approve Board Changes and Proposals for Improved Corporate Governance
London (ots/PRNewswire) - - Turkcell has a weak governance regime - These problems have led to poor operating and strategic performance, low valuation and loss of investor confidence LetterOne, the holder of a 19.8% economic interest in Turkcell Iletisim Hizmetleri A.S. (the "Company" or "Turkcell") through its ...
plus- 2
FDI World Dental Federation launches the Mouth Proud Challenge and asks how do you take care of your oral health?
plus DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
plusCyberMDX Healthcare Security Suite Release 5.0 Takes on the Ransomware Epidemic
New York (ots/PRNewswire) - Global Healthcare security leader introduces intelligent mitigation actioning into latest release - and launches two new offerings, including the industry's first IoT Security Freemium edition for healthcare organizations who need help now CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for ...
plus
Accord's SONDELBAY ®▼ (teriparatide) is given Green Light by CHMP
Harrow, England (ots/PRNewswire) - Sondelbay – is a self-administered, once-a-day subcutaneous injection for patients with osteoporosis using a pen device - Accord's fourth biosimilar, joins the company's established portfolio across Europe, and marks its first branded product in a new Bone Health franchise representing another great milestone in Accord's growing ...
plusMicreos appoints Joost Goderie as CFO and member of the Board of Directors
The Hague, The Netherlands (ots/PRNewswire) - Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its targeted antibacterial technology to the world. He will be responsible for ...
plusKLӦCKNER PENTAPLAST COMMITS TO rPET/PET CAPACITY EXPANSION FOR THE SUSTAINABLE HEALTHCARE AND FOOD PACKAGING MARKET IN NORTH AMERICA
London (ots/PRNewswire) - Klöckner Pentaplast (kp), a global leader in recycled content products and high-barrier protective packaging, has announced its intention to expand its post-consumer recycled content (PCR) PET capacity in North America with a significant investment to further grow its sustainable ...
plusNanoPass's intradermal delivery platform used in Emergex's next generation COVID-19 vaccination study
Nes Ziona, Israel (ots/PRNewswire) - Intradermal COVID-19 vaccination studies are emerging in a global effort to use available doses more effectively by harnessing skin immunity to reduce the dosage required for effective vaccination, as well as to improve the immunogenicity of weaker vaccines. Additionally, there ...
plusgenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology
Lyon, France (ots/PRNewswire) - genOway, a world leader in the field of genetically modified innovative research models, announced today that it has granted a non-exclusive CRISPR/Cas9 license to the most important funding institution of biomedical academic research in the United Kingdom. In December 2018, genOway ...
plusParity Technologies and MediLedger Network Announce Partnership to Deliver Blockchain-Powered Solutions to the Life Sciences Industry
San Francisco (ots/PRNewswire) - Companies to apply technology originally developed to address drug safety, to pricing accuracy, chargeback automation, and other supply chain solutions Chronicled, the technology company behind MediLedger Network, has entered into a partnership with Parity Technologies, the developer ...
plus
Zentiva awarded Top Employer accolade
Prague (ots/PRNewswire) - The Top Employee Institute has certified Zentiva as a Top Employer. This prestigious award was received for Zentiva's exceptional standards across 6 Human Resources-domains in its home countries the Czech Republic and Romania. The assessment was covering 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion, and many more. "I am ...
plusServier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline
Paris (ots/PRNewswire) - - Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerated oncology strategy with the acquisition of ...
plusOri Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
London (ots/PRNewswire) - Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B funding round. The investment round was led by Novalis LifeSciences with Puhua Capital and Chimera Abu Dhabi coming in as ...
plusDALI Medical's SAN®Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
Tel Aviv, Israel (ots/PRNewswire) - DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle. SAN-Light was chosen to be used with ADVANZ PHARMA's MYTOLAC®/MYRELEZ® - the first generic ...
plusEssence Group Announces Success in Meeting Supply Demand Throughout 2021, Despite Major Chip Shortages Caused by Ongoing COVID-19 Disruption
Herzliya, Israel (ots/PRNewswire) - Efficient Supply Chain Management, Including Advanced Forecasting and Component Sourcing, Resulted in Essence's 99.5% On-Time Delivery of Customer Orders Essence Group, a leading technology group developing IoT-based security, safety and healthcare solutions and cloud services for ...
plusCardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council
Caesarea, Israel (ots/PRNewswire) - Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of Filterlex's next round of financing. ...
plus
Novaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
Heidelberg, Germany and Cambridge, Mass (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug ...
plusOrganOx receives FDA approval for its liver normothermic machine perfusion system
Oxford, England (ots/PRNewswire) - OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its metra system. The OrganOx metra is a fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing ...
plusNorgine B.V. announces Senior Management changes: Christopher Bath appointed Chief Executive Officer - Peter Stein to assume role of Executive Chairman
Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announces that Christopher Bath has been appointed Chief Executive Officer (CEO) effective 1st January 2022. Chris will be responsible for a business with a portfolio of market leading medicinal products ...
plusPHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the ...
plusBenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca's portfolio
London (ots/PRNewswire) - - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to ...
plusMenarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting
Bologna, Italy and Huntingdon Valley, Pa. (ots/PRNewswire) - Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating ...
plus
Précédent567891011121314Suivant